PLA2G6 and prion disease: The importance of PLA2 in the pathogenesis of the neuronal degeneration in prion diseases has been indicated by the use of PLA2 inhibitors that reduced PrPSc formation caspase-3 activity and prostaglandin E2 production[11,13,22].